Table 3.
Survival | Histopathology | HR | 95% CI | p-Value | |
---|---|---|---|---|---|
LB | UB | ||||
OS | 2 tier CRS (1/2 versus 3) | 0.49 | 0.25 | 0.95 | 0.034 |
Oncocytic change (0/1 versus 2/3) | 0.63 | 0.42 | 0.93 | 0.020 | |
Inflammation (0/1 versus 2/3) | 0.60 | 0.41 | 0.87 | 0.007 | |
Desmoplasia (0/1 versus 2/3) | 1.67 | 1.13 | 2.47 | 0.010 | |
PFS | 2 tier CRS (1/2 versus 3) | 0.52 | 0.31 | 0.87 | 0.012 |
Inflammation (0/1 versus 2/3) | 0.63 | 0.46 | 0.85 | 0.003 | |
Desmoplasia (0/1 versus 2/3) | 1.48 | 1.09 | 2.01 | 0.011 |
Hazard ratio, HR; confidence interval, CI; lower bound, LB; upper bound, UB.